InvestorsHub Logo
Followers 90
Posts 17400
Boards Moderated 0
Alias Born 09/06/2006

Re: DewDiligence post# 4764

Friday, 08/24/2007 9:21:08 AM

Friday, August 24, 2007 9:21:08 AM

Post# of 19309
At N=50 (in the subgroup), the lack of stat sig. mortality is not surpising, but the overall DIC benifit looked promising.

Question, since ART-123 works on the APC pathway would this be expected to behave similarly to Xigris (recmbinant APC)?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.